These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 31369106)
1. Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan. Bakhiet AMA; Abdelraheem MH; Kheir A; Omer S; Gismelseed L; Abdel-Muhsin AA; Naiem A; Al Hosni A; Al Dhuhli A; Al Rubkhi M; Al-Hamidhi S; Gadalla A; Mukhtar M; Sultan AA; Babiker HA Trans R Soc Trop Med Hyg; 2019 Nov; 113(11):693-700. PubMed ID: 31369106 [TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy. Guerra M; Neres R; Salgueiro P; Mendes C; Ndong-Mabale N; Berzosa P; de Sousa B; Arez AP Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795385 [TBL] [Abstract][Full Text] [Related]
3. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda. Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575 [TBL] [Abstract][Full Text] [Related]
4. Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan. Gadalla NB; Abdallah TM; Atwal S; Sutherland CJ; Adam I Malar J; 2013 Jul; 12():255. PubMed ID: 23870667 [TBL] [Abstract][Full Text] [Related]
5. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers. Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India. Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538 [TBL] [Abstract][Full Text] [Related]
7. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India. Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Wurtz N; Fall B; Pascual A; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Bercion R; Briolant S; Wade B; Pradines B Malar J; 2012 Jun; 11():197. PubMed ID: 22694921 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan. Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587 [TBL] [Abstract][Full Text] [Related]
10. Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan. Mohamed AO; Hussien M; Mohamed A; Suliman A; Elkando NS; Abdelbagi H; Malik EM; Abdelraheem MH; Hamid MMA Malar J; 2020 Feb; 19(1):78. PubMed ID: 32070355 [TBL] [Abstract][Full Text] [Related]
11. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes. Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J Malar J; 2016 May; 15(1):295. PubMed ID: 27234587 [TBL] [Abstract][Full Text] [Related]
12. A snapshot of Plasmodium falciparum malaria drug resistance markers in Sudan: a pilot study. Mohamed NS; Abdelbagi H; Osman HA; Ahmed AE; Yousif AM; Edris YB; Osman EY; Elsadig AR; Siddig EE; Mustafa M; Mohammed AA; Ali Y; Osman MM; Ali MS; Omer RA; Ahmed A; Sibley CH BMC Res Notes; 2020 Nov; 13(1):512. PubMed ID: 33160417 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border. Ould Ahmedou Salem MS; Mint Lekweiry K; Bouchiba H; Pascual A; Pradines B; Ould Mohamed Salem Boukhary A; Briolant S; Basco LK; Bogreau H Malar J; 2017 Apr; 16(1):140. PubMed ID: 28381273 [TBL] [Abstract][Full Text] [Related]
14. Molecular Evidence for Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146 [TBL] [Abstract][Full Text] [Related]
15. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea). Berzosa P; Esteban-Cantos A; García L; González V; Navarro M; Fernández T; Romay-Barja M; Herrador Z; Rubio JM; Ncogo P; Santana-Morales M; Valladares B; Riloha M; Benito A Malar J; 2017 Jan; 16(1):28. PubMed ID: 28086777 [TBL] [Abstract][Full Text] [Related]
16. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849 [TBL] [Abstract][Full Text] [Related]
17. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017. Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665 [TBL] [Abstract][Full Text] [Related]
18. Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016-2020: Clinical and genetic studies. Adam M; Nahzat S; Kakar Q; Assada M; Witkowski B; Tag Eldin Elshafie A; Abuobaida D; Safi N; Khan MA; Nagi M; Mustafa SA; Kohestani K; Muhammad J; Khim N; Al-Hadi M; Elfaki TM; Habib MN; Khairy AKA; Hamid H; Uddin Z; Amer Y; Hassan AH; Elhag MS; Sediqi AW; Kakar I; Abdul-Ghani R; Amran JGH; Abdallrahim TA; Tamim MS; Aljasari A; Rasmussen C; Azkoul L; Warsame M Trop Med Int Health; 2023 Oct; 28(10):817-829. PubMed ID: 37705047 [TBL] [Abstract][Full Text] [Related]
19. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran. Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304 [TBL] [Abstract][Full Text] [Related]
20. Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon. Niba PTN; Nji AM; Chedjou JPK; Hansson H; Hocke EF; Ali IM; Achonduh-Atijegbe O; Evehe MB; Jørgensen MHM; Fomboh CT; Cui L; Stresman G; Bigoga JD; Alifrangis M; Mbacham WF Int J Infect Dis; 2023 Jul; 132():108-117. PubMed ID: 37028468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]